(Q38164196)

30 August 2017

title

Harnessing local and systemic immunity for vaccines against tuberculosis (English)

1 reference

30 August 2017

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24253104%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Peter Beverley

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24253104%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Ajit Lalvani

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24253104%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Elma Z Tchilian

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24253104%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

author name string

P C L Beverley

1

1 reference

30 August 2017

E Z Tchilian

4

1 reference

30 August 2017

publication date

20 November 2013

1 reference

30 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24253104%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24253104%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24253104%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

20-26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24253104%20AND%20SRC:MED&resulttype=core&format=json

Bettering BCG: a tough task for a TB vaccine?

7 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Lessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Immunogenicity and protective efficacy of prime-boost regimens with recombinant (delta)ureC hly+ Mycobacterium bovis BCG and modified vaccinia virus ankara expressing M. tuberculosis antigen 85A against murine tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Establishment of an aerosol challenge model of tuberculosis in rhesus macaques and an evaluation of endpoints for vaccine testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Multiple immunizations with adenovirus and MVA vectors improve CD8+ T cell functionality and mucosal homing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Control of chronic mycobacterium tuberculosis infection by CD4 KLRG1- IL-2-secreting central memory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Cellular immune responses induced in cattle by heterologous prime-boost vaccination using recombinant viruses and bacille Calmette-Guérin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

The immunological life cycle of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Understanding delayed T-cell priming, lung recruitment, and airway luminal T-cell responses in host defense against pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

ESAT-6-specific CD4 T cell responses to aerosol Mycobacterium tuberculosis infection are initiated in the mediastinal lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Cell-mediated immune responses in tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Mechanisms of delayed anti-tuberculosis protection in the lung of parenteral BCG-vaccinated hosts: a critical role of airway luminal T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Simultaneous immunization against tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Early T-cell responses in tuberculosis immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

A key role for lung-resident memory lymphocytes in protective immune responses after BCG vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Skin infection generates non-migratory memory CD8+ T(RM) cells providing global skin immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Enhanced survival of lung tissue-resident memory CD8⁺ T cells during infection with influenza virus due to selective expression of IFITM3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Activated antigen-specific CD8+ T cells persist in the lungs following recovery from respiratory virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Resident memory T cells (T(RM)) are abundant in human lung: diversity, function, and antigen specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Resident Th1-like effector memory cells in pulmonary recall responses to Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Genetic immunization in the lung induces potent local and systemic immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Upper airway x 1: allergic rhinitis and asthma: united disease through epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Upper airway. 3: Sinonasal involvement in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Mechanisms of mucosal and parenteral tuberculosis vaccinations: adenoviral-based mucosal immunization preferentially elicits sustained accumulation of immune protective CD4 and CD8 T cells within the airway lumen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Immunization of mice with a recombinant adenovirus vaccine inhibits the early growth of Mycobacterium tuberculosis after infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

CXCR6 is a marker for protective antigen-specific cells in the lungs after intranasal immunization against Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Murine airway luminal antituberculosis memory CD8 T cells by mucosal immunization are maintained via antigen-driven in situ proliferation, independent of peripheral T cell recruitment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Lymphocyte homing to bronchus-associated lymphoid tissue (BALT) is mediated by L-selectin/PNAd, alpha4beta1 integrin/VCAM-1, and LFA-1 adhesion pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Interleukin-17-dependent CXCL13 mediates mucosal vaccine-induced immunity against tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Regulation of TB vaccine-induced airway luminal T cells by respiratory exposure to endotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Cytokine profile of t lymphocytes from peripheral blood and bronchoalveolar lavage fluid in patients with active pulmonary tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Efficacy and safety of live attenuated persistent and rapidly cleared Mycobacterium tuberculosis vaccine candidates in non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

A critical role for CD8 T cells in a nonhuman primate model of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Immune biology of macaque lymphocyte populations during mycobacterial infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Evaluation of the safety and immunogenicity of a candidate tuberculosis vaccine, MVA85A, delivered by aerosol to the lungs of macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Immunogenicity comparison of the intradermal or endobronchial boosting of BCG vaccinates with Ad5-85A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Role of innate cytokines in mycobacterial infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Preexisting helminth infection induces inhibition of innate pulmonary anti-tuberculosis defense by engaging the IL-4 receptor pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Mycobacterium bovis-BCG vaccination induces specific pulmonary transcriptome biosignatures in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Modulation of immune homeostasis by commensal bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Differential expression of Toll-like receptors on human alveolar macrophages and autologous peripheral monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Pulmonary surfactant protein A and surfactant lipids upregulate IRAK-M, a negative regulator of TLR-mediated inflammation in human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Pulmonary surfactant protein A regulates TLR expression and activity in human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Human lung immunity against Mycobacterium tuberculosis: insights into pathogenesis and protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Differentially imprinted innate immunity by mucosal boost vaccination determines antituberculosis immune protective outcomes, independent of T-cell immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Alteration of epitope recognition pattern in Ag85B and ESAT-6 has a profound influence on vaccine-induced protection against Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Cytomegalovirus vectors violate CD8+ T cell epitope recognition paradigms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Immunization with different formulations of Mycobacterium tuberculosis antigen 85A induces immune responses with different specificity and protective efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Preclinical evidence for implementing a prime-boost vaccine strategy for tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Jump-starting the immune system: prime-boosting comes of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Viruses as vaccine vectors for infectious diseases and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

T cell vaccines for microbial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

A multistage tuberculosis vaccine that confers efficient protection before and after exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

The HyVac4 subunit vaccine efficiently boosts BCG-primed anti-mycobacterial protective immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Intranasal mucosal boosting with an adenovirus-vectored vaccine markedly enhances the protection of BCG-primed guinea pigs against pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Airborne immunization against tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Aerogenic BCG vaccination against tuberculosis in animal and human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Alternative routes of measles immunization: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.99

Pulmonary mononuclear cell responses to antigens of Mycobacterium tuberculosis in healthy household contacts of patients with active tuberculosis and healthy controls from the community

21 January 2018

1 reference

12 December 2020

Heterosubtypic immunity to influenza type A virus in mice. Effector mechanisms and their longevity.

1 reference

12 December 2020

T lymphocytic and immature macrophage alveolitis in active pulmonary tuberculosis

1 reference

12 December 2020

Protection of monkeys against airborne tuberculosis by aerosol vaccination with bacillus Calmette-Guerin

1 reference

12 December 2020

Nasal associated lymphoid tissue (NALT) contributes little to protection against aerosol challenge with Mycobacterium tuberculosis after immunisation with a recombinant adenoviral vaccine

1 reference

12 December 2020

Heterologous boost vaccines for bacillus Calmette-Guérin prime immunization against tuberculosis

1 reference

12 December 2020

Protection of cattle from bovine tuberculosis by vaccination with BCG by the respiratory or subcutaneous route, but not by vaccination with killed Mycobacterium vaccae

1 reference

12 December 2020

Tuberculosis vaccines: time to reset the paradigm?

1 reference

12 December 2020